A Phase II Study of Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide (DVD-R) for Patients With Relapsed/Refractory Multiple Myeloma.
Phase of Trial: Phase II
Latest Information Update: 07 May 2015
At a glance
- Drugs Lenalidomide (Primary) ; Bortezomib; Dexamethasone; Doxorubicin liposomal
- Indications Multiple myeloma
- Focus Therapeutic Use
- 01 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jun 2011 Planned end date changed from 1 Dec 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.
- 13 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.